Trial Profile
Switching to everolimus versus continuing tacrolimus in renal transplant recipients: the ERIC study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Corticosteroids; Mycophenolate sodium; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ERIC
- 04 May 2011 Results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
- 15 Aug 2010 Results presented at the 23rd International Congress of the Transplantation Society 2010.
- 05 Jul 2010 New trial record